These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

400 related items for PubMed ID: 16236883

  • 1. Double-cycle, high-dose ifosfamide, carboplatin, and etoposide followed by peripheral blood stem-cell transplantation for small cell lung cancer.
    Iwasaki Y, Nagata K, Nakanishi M, Natuhara A, Kubota Y, Ueda M, Arimoto T, Hara H.
    Chest; 2005 Oct; 128(4):2268-73. PubMed ID: 16236883
    [Abstract] [Full Text] [Related]

  • 2. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Frommhold H, Pressler K, Mertelsmann R, Kanz L.
    Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
    [Abstract] [Full Text] [Related]

  • 3. High-dose ifosfamide, carboplatin and etoposide with autologous peripheral blood progenitor cell transplantation for small-cell lung cancer.
    Bessho A, Ueoka H, Kiura K, Tabata M, Sunami K, Katayama Y, Yamane H, Hiraki A, Harada M.
    Anticancer Res; 1999 Feb; 19(1B):693-8. PubMed ID: 10216478
    [Abstract] [Full Text] [Related]

  • 4. Dose-intense therapy with etoposide, ifosfamide, cisplatin, and epirubicin (VIP-E) in 100 consecutive patients with limited- and extensive-disease small-cell lung cancer.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Wenger M, Lange W, Mertelsmann R.
    Ann Oncol; 1997 Jan; 8(1):49-56. PubMed ID: 9093707
    [Abstract] [Full Text] [Related]

  • 5. A phase I dose escalation study of multicyclic, dose-intensive chemotherapy with peripheral blood stem cell support for small cell lung cancer.
    Takahashi M, Yoshizawa H, Tanaka H, Tanaka J, Kagamu H, Ito K, Shimbo T, Chou D, Wakabayashi M, Suzuki E, Sakai K, Arakawa M, Gejyo F.
    Bone Marrow Transplant; 2000 Jan; 25(1):5-11. PubMed ID: 10654007
    [Abstract] [Full Text] [Related]

  • 6. Standard- and high-dose etoposide, ifosfamide, carboplatin, and epirubicin in 100 patients with small-cell lung cancer: a mature follow-up report.
    Fetscher S, Brugger W, Engelhardt R, Kanz L, Hasse J, Frommhold H, Lange W, Mertelsmann R.
    Ann Oncol; 1999 May; 10(5):561-7. PubMed ID: 10416006
    [Abstract] [Full Text] [Related]

  • 7. Multimodality treatment including early high-dose chemotherapy with peripheral blood stem cell transplantation in limited-disease small cell lung cancer.
    Brugger W, Fetscher S, Hasse J, Frommhold H, Pressler K, Mertelsmann R, Engelhardt R, Kanz L.
    Semin Oncol; 1998 Feb; 25(1 Suppl 2):42-8. PubMed ID: 9535211
    [Abstract] [Full Text] [Related]

  • 8. [Mega-dose chemotherapy with peripheral blood stem cell transplantation (PBS-CT) for small cell lung cancer (SCLC)].
    Chou T, Yokoyama A, Yoshizawa H, Hoshino M, Ebe T, Kurita Y, Arakawa M.
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1741-8. PubMed ID: 7574804
    [Abstract] [Full Text] [Related]

  • 9. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
    Leyvraz S, Pampallona S, Martinelli G, Ploner F, Perey L, Aversa S, Peters S, Brunsvig P, Montes A, Lange A, Yilmaz U, Rosti G, Solid Tumors Working Party of the European Group for Blood and Marrow Transplantation.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):533-41. PubMed ID: 18398095
    [Abstract] [Full Text] [Related]

  • 10. Cisplatin/etoposide versus ifosfamide/etoposide combination chemotherapy in small-cell lung cancer: a multicenter German randomized trial.
    Wolf M, Havemann K, Holle R, Gropp C, Drings P, Hans K, Schroeder M, Heim M, Dommes M, Mende S.
    J Clin Oncol; 1987 Dec 16; 5(12):1880-9. PubMed ID: 2824710
    [Abstract] [Full Text] [Related]

  • 11. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K, Wolf M, Drings P, Hans K, Schroeder M, Holle R, Flechtner H, Goerg R, Becker H.
    Semin Oncol; 1989 Feb 16; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [Abstract] [Full Text] [Related]

  • 12. Phase II study of irinotecan plus cisplatin induction followed by concurrent twice-daily thoracic irradiation with etoposide plus cisplatin chemotherapy for limited-disease small-cell lung cancer.
    Han JY, Cho KH, Lee DH, Kim HY, Kim EA, Lee SY, Lee JS.
    J Clin Oncol; 2005 May 20; 23(15):3488-94. PubMed ID: 15908658
    [Abstract] [Full Text] [Related]

  • 13. [Invasive thymoma successfully treated with high-dose chemotherapy followed by peripheral blood stem cell transplantation(PBSCT)].
    Iwasaki Y, Kubota Y, Yokomura I, Ueda M, Hashimoto S, Arimoto T, Inaba T, Shimazaki C, Nakagawa M, Toda S.
    Nihon Kokyuki Gakkai Zasshi; 1998 Mar 20; 36(3):288-93. PubMed ID: 9656679
    [Abstract] [Full Text] [Related]

  • 14. Phase II study of ifosfamide, carboplatin, and oral etoposide chemotherapy for extensive-disease small-cell lung cancer: an Eastern Cooperative Oncology Group pilot study.
    Wolff AC, Ettinger DS, Neuberg D, Comis RL, Ruckdeschel JC, Bonomi PD, Johnson DH.
    J Clin Oncol; 1995 Jul 20; 13(7):1615-22. PubMed ID: 7602350
    [Abstract] [Full Text] [Related]

  • 15. Sequential high-dose chemotherapy with autologous stem cell support in patients with limited-stage small cell lung cancer.
    Ziske C, Gorschlüter M, Mey U, Offergeld R, Glasmacher A, Schmidt-Wolf IG.
    Anticancer Res; 2002 Jul 20; 22(6B):3723-6. PubMed ID: 12552983
    [Abstract] [Full Text] [Related]

  • 16. Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
    Steward WP, von Pawel J, Gatzemeier U, Woll P, Thatcher N, Koschel G, Clancy L, Verweij J, de Wit R, Pfeifer W, Fennelly J, von Eiff M, Frisch J.
    J Clin Oncol; 1998 Feb 20; 16(2):642-50. PubMed ID: 9469353
    [Abstract] [Full Text] [Related]

  • 17. Treatment of germ cell cancer with two cycles of high-dose ifosfamide, carboplatin, and etoposide with autologous stem-cell support.
    Margolin K, Doroshow JH, Ahn C, Hamasaki V, Leong L, Morgan R, Raschko J, Shibata S, Somlo G, Tetef M.
    J Clin Oncol; 1996 Oct 20; 14(10):2631-7. PubMed ID: 8874321
    [Abstract] [Full Text] [Related]

  • 18. A combination chemotherapy of carboplatin and irinotecan with granulocyte colony-stimulating factor (G-CSF) support in elderly patients with small cell lung cancer.
    Okamoto H, Naoki K, Narita Y, Hida N, Kunikane H, Watanabe K.
    Lung Cancer; 2006 Aug 20; 53(2):197-203. PubMed ID: 16781005
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of ifosfamide in combination with carboplatin and etoposide in small cell lung cancer.
    Lee HS, Lee YG, Koo DH, Oh S, Nam H, Song JU, Lim SY, Lim SY, Lee SS.
    Cancer Chemother Pharmacol; 2015 Nov 20; 76(5):933-7. PubMed ID: 26374553
    [Abstract] [Full Text] [Related]

  • 20. High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.
    Siegert W, Beyer J, Strohscheer I, Baurmann H, Oettle H, Zingsem J, Zimmermann R, Bokemeyer C, Schmoll HJ, Huhn D.
    J Clin Oncol; 1994 Jun 20; 12(6):1223-31. PubMed ID: 7911158
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.